by soxedoze | Oct 31, 2018 | Events, KVV/OAmal
The Rare Disease Action Forum holds an international event on the topic of “value assessment of orphan drugs in Switzerland and the EU” on 31 October 2018 in Basel, Switzerland Experts from authorities, patient organizations and the industry will provide insights to... by soxedoze | Oct 5, 2016 | BAG/OFSP, KVV/OAmal, Publications
The RDAF provided input to the public consultation launched by the Federal Office of Public Health (FOPH) on the Swiss Ordinance on Health Insurance (KVV/OAMal). The RDAF’s input included action oriented suggestions for improving patient access to treatment and...